| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |